Replicate Bioscience, Inc.

United States of America

Create a watch for Replicate Bioscience, Inc.
Total IP 43
Total IP Rank # 33,664
IP Activity Score 2.5/5.0    40
IP Activity Rank # 18,616
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

14 1
13 0
15 0
0
 
Last Patent 2025 - Modified western equine encephal...
First Patent 2021 - Modified chikungunya viruses and...
Last Trademark 2021 - REPLICATE
First Trademark 2021 - REPLICATE

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Compositions and methods for inducing immune response against epstein-barr viruses. e.ge.g., self...
Invention Compositions and methods for expression of egfr. The present disclosure relates to modified viral...
Invention System and method for cardiopulmonary bypass using hypobaric oxygenation. A system for cardiopul...
Invention Compositions and methods for expression of il-1ra and il-18bp. The present disclosure relates to ...
Invention Methods for identification and selection of self-replicating rna molecules for biomedical applica...
2023 Invention Modified madariaga viruses, self-replicating rna constructs, and uses thereof. The present disclo...
Invention Modified western equine encephalitis viruses and uses thereof. The present disclosure relates to...
Invention Modified western equine encephalitis viruses and uses thereof. The present disclosure relates to ...
Invention Compositions and methods for the prevention and treatment of rabies virus infection. The present...
Invention Compositions and methods for the prevention and treatment of rabies virus infection. The present ...
Invention Methods for generating functional self-replicating rna molecules. The present disclosure relates...
Invention Methods for generating functional self-replicating rna molecules. de novode novo functional srRNA...
2022 Invention Compositions and methods for expression of il-12 and il-1ra. The present disclosure relates to t...
Invention Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responses. The present d...
Invention Methods of generating self-replicating rna molecules. The present disclosure generally relates t...
Invention Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responses. The present di...
Invention Methods of generating self-replicating rna molecules. The present disclosure generally relates to...
Invention Modified alphaviruses with heterologous nonstructural proteins. The present disclosure relates t...
Invention Modified alphaviruses with heterologous nonstructural proteins. e.g.e.g., self-replicating RNAs),...
Invention Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof. ...
Invention Alphavirus vectors containing universal cloning adaptors. The present disclosure relates to the ...
Invention Alphavirus vectors containing universal cloning adaptors. e.ge.g., self-replicating RNAs), pharma...
2021 G/S Pharmaceutical and biologic preparations for the treatment of cancer, autoimmune disorders and di...
Invention Compositions and methods for expression of il-12 and il-1ra. The present disclosure relates to th...
Invention Modified chikungunya viruses and sindbis viruses and uses thereof. The present disclosure relate...
Invention Modified chikungunya viruses and sindbis viruses and uses thereof. The present disclosure relates...